Related references
Note: Only part of the references are listed.Novel 1,3,4-thiadiazoles inhibit colorectal cancer via blockade of IL-6/COX-2 mediated JAK2/STAT3 signals as evidenced through data-based mathematical modeling
Vinit Raj et al.
CYTOKINE (2019)
Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis
Jun Ho Lee et al.
GUT (2019)
Melatonin application in targeting oxidative-induced liver injuries: A review
Keywan Mortezaee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin
Fuli Wang et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer
Emily L. Rossi et al.
MOLECULAR CARCINOGENESIS (2018)
Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer
Emilio P. Araujo-Mino et al.
ONCOLOGIST (2018)
Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
Benjamin M. Wahle et al.
ONCOTARGET (2018)
Celecoxib-Induced Self-Assembly of Smart Albumin-Doxorubicin Conjugate for Enhanced Cancer Therapy
Leilei Shi et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients
Karla Esbona et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Celecoxib Conjugated Fluorescent Probe for Identification and Discrimination of Cyclooxygenase-2 Enzyme in Cancer Cells
Bhaskar Gurram et al.
ANALYTICAL CHEMISTRY (2018)
Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell-cancer interactions
Xiaoshan Yue et al.
BIOMATERIALS (2018)
The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of experimental colorectal cancer
Hilal Gungor et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Gramine attenuates EGFR-mediated inflammation and cell proliferation in oral carcinogenesis via regulation of NF-κB and STAT3 signaling
Arunkumar Ramu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Anti-inflammatory and anti-tumor effects of α-L-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model
Fatemeh Hosseini et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism
Yi Xu et al.
BMC CANCER (2018)
C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells
Liangqian Jiang et al.
CANCER CELL INTERNATIONAL (2018)
Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process
Corina Behrenbruch et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Separation of plasma-derived exosomes into CD3(+) and CD3(-) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients
M-N Theodoraki et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment
Xiao-Feng Dong et al.
CLINICAL CANCER RESEARCH (2018)
Chlorinated cobalt alkyne complexes derived from acetylsalicylic acid as new specific antitumor agents
Victoria Obermoser et al.
DALTON TRANSACTIONS (2018)
Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells
Yu Tang Chin et al.
ENDOCRINE-RELATED CANCER (2018)
Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells
Jade K. Pollock et al.
INVESTIGATIONAL NEW DRUGS (2018)
Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies
Wei Xu et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Nicotine increases colon cancer cell migration and invasion through epithelial to mesenchymal transition (EMT): COX-2 involvement
Simona Dinicola et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Inflammasome: Its role in traumatic brain and spinal cord injury
Keywan Mortezaee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Human hepatocellular carcinoma: Protection by melatonin
Keywan Mortezaee
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy
Jiaojiao Hao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Thiazoles and Thiazolidinones as COX/LOX Inhibitors
Konstantinos Liaras et al.
MOLECULES (2018)
Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer
Shreena J. Desai et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2018)
COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma
Marco Aurelio Petroni Montezuma et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy
Jon Kirk et al.
SUPPORTIVE CARE IN CANCER (2018)
Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis
Ping Dai et al.
ONCOTARGETS AND THERAPY (2018)
Proton irradiation orchestrates macrophage reprogramming through NF kappa B signaling
Geraldine Genard et al.
CELL DEATH & DISEASE (2018)
Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression
Wei Xiang et al.
NATURE COMMUNICATIONS (2018)
Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors
Alicia Beeghly-Fadiel et al.
JOURNAL OF OVARIAN RESEARCH (2018)
Preventive Potential of Resveratrol in Carcinogen-Induced Rat Thyroid Tumorigenesis
Xu Zheng et al.
NUTRIENTS (2018)
Stromal versus tumoral inflammation differentially contribute to metastasis and poor survival in laryngeal squamous cell carcinoma
Benedikt Höing et al.
Oncotarget (2018)
The metal-nonoate Ni(SalPipNONO) inhibits in vitro tumor growth, invasiveness and angiogenesis
Valerio Ciccone et al.
Oncotarget (2018)
Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers
Junko Ohtsuka et al.
SCIENTIFIC REPORTS (2018)
COX-2 induces oncogenic micro RNA miR655 in human breast cancer
Mousumi Majumder et al.
SCIENTIFIC REPORTS (2018)
Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation
Shigeki Ikeya et al.
SCIENTIFIC REPORTS (2018)
Molecular Insights into the Interaction of RONS and Thieno[3,2-c]pyran Analogs with SIRT6/COX-2: A Molecular Dynamics Study
Dharmendra K. Yadav et al.
SCIENTIFIC REPORTS (2018)
Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation
Zhihang Chen et al.
THERANOSTICS (2018)
Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling
Whitney S. Henry et al.
CANCER RESEARCH (2017)
Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma
H. Janakiraman et al.
ONCOGENE (2017)
Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma
Qi Zhao et al.
ONCOTARGET (2017)
Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk
Yong Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Adaptor protein p62 promotes skin tumor growth and metastasis and is induced by UVA radiation
Ashley Sample et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades
Xun Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
Wei Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer
Qinghong Guo et al.
MEDICINE (2017)
Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
Jingshu Wang et al.
MOLECULAR CANCER (2017)
Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention
Ning Zheng et al.
MOLECULAR CARCINOGENESIS (2017)
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis
C-J Ko et al.
ONCOGENE (2017)
Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice
H. Chen et al.
ONCOGENE (2017)
Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells
Aleksandra Barac et al.
ONCOTARGETS AND THERAPY (2017)
Curcumin potentiates the potent antitumor activity of ACN against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways
Jun Zhao et al.
ONCOTARGETS AND THERAPY (2017)
Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts
Balaji Krishnamachary et al.
ONCOTARGET (2017)
EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
Xiaoping Wang et al.
Oncotarget (2017)
Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma
Megan Wu et al.
ONCOTARGET (2017)
Cyclooxygenase-2 mediated synergistic effect of ursolic acid in combination with paclitaxel against human gastric carcinoma
Xian Xu et al.
ONCOTARGET (2017)
COX-2 expression in ovarian cancer: an updated meta-analysis
Haiming Sun et al.
ONCOTARGET (2017)
Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-ζ-nuclear factor-κB signaling pathway in prostate cancer cells
Hyoung-Seok Baek et al.
ONCOTARGET (2017)
Mifepristone inhibits ovarian cancer metastasis by intervening in SDF-1/CXCR4 chemokine axis
Ning Zheng et al.
ONCOTARGET (2017)
1,8-cineole prevents UVB-induced skin carcinogenesis by targeting the aryl hydrocarbon receptor
Jangho Lee et al.
ONCOTARGET (2017)
Reactive oxygen species dependent phosphorylation of the liver kinase B1/AMP activated protein kinase/acetyl-CoA carboxylase signaling is critically involved in apoptotic effect of lambertianic acid in hepatocellular carcinoma cells
Arong Jeong et al.
ONCOTARGET (2017)
COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor
Junyang Li et al.
ONCOTARGET (2017)
Specific role of RhoC in tumor invasion and metastasis
Sarah Lang et al.
ONCOTARGET (2017)
Prostaglandin E2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment
Jie Miao et al.
ONCOTARGET (2017)
SerpinB3 upregulates the Cyclooxygenase-2/β-Catenin positive loop in colorectal cancer
Liliana Terrin et al.
ONCOTARGET (2017)
Radiosensitizing effect of ellagic acid on growth of Hepatocellular carcinoma cells: an in vitro study
Ujjal Das et al.
SCIENTIFIC REPORTS (2017)
Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the ApcMin/+ mouse model of intestinal tumorigenesis
Mark A. Hull et al.
SCIENTIFIC REPORTS (2017)
Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related-protein 1
Teng-Jian Zhou et al.
THERANOSTICS (2017)
LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma
Ting-Ting Cai et al.
PLOS PATHOGENS (2017)
Curcumin Enhances the Anticancer Effect Of 5-fluorouracil against Gastric Cancer through Down-Regulation of COX-2 and NF-kappa B Signaling Pathways
Hongru Yang et al.
JOURNAL OF CANCER (2017)
Establishment of optimal regulatory network of colorectal cancer based on p42.3 protein
Yibin Hao et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2017)
Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
Marc Hennequart et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms' Tumor
Paramahamsa Maturu et al.
NEOPLASIA (2017)
Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells
Xiaoyu Yang et al.
REDOX BIOLOGY (2017)
Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer
Hai Hu et al.
SCIENTIFIC REPORTS (2017)
Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
Jun Tian et al.
SCIENTIFIC REPORTS (2017)
Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution
Hwa Hwa Chung et al.
SCIENTIFIC REPORTS (2017)
miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H-pylori gastric cancer models
Xuan Liu et al.
SCIENTIFIC REPORTS (2017)
Store-operated Ca2+ Entry Facilitates the Lipopolysaccharide-induced Cyclooxygenase-2 Expression in Gastric Cancer Cells
Jhen-Hong Wong et al.
SCIENTIFIC REPORTS (2017)
Autophagy gene ATG7 regulates ultraviolet radiation-induced inflammation and skin tumorigenesis
Lei Qiang et al.
AUTOPHAGY (2017)
Sphingosine Kinase 1 expression in peritoneal macrophages is required for colon carcinogenesis
Hideki Furuya et al.
CARCINOGENESIS (2017)
Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer
Yawei Zhao et al.
CELL PROLIFERATION (2017)
Mechanisms of action of nonpeptide hormones on resveratrol-induced antiproliferation of cancer cells
Hung-Yun Lin et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation
Bailong Li et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
A reactive oxygen species-generating, cyclooxygenase-2 inhibiting, cancer stem cell-potent tetranuclear copper(II) cluster
C. Lu et al.
DALTON TRANSACTIONS (2017)
Cancer Stem Cell and Bulk Cancer Cell Active Copper(II) Complexes with Vanillin Schiff Base Derivatives and Naproxen
Chunxin Lu et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial
Lee Shaashua et al.
CLINICAL CANCER RESEARCH (2017)
Hypoxia-Induced Downregulation of DUSP-2 Phosphatase Drives Colon Cancer Stemness
Pei-Chi Hou et al.
CANCER RESEARCH (2017)
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer
Antonella Brizzolara et al.
CANCER LETTERS (2017)
Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues
Ravikumar Muthuswamy et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis
Dali Tong et al.
CANCER LETTERS (2017)
Cyclooxygenase-2 in glioblastoma multiforme
Jiange Qiu et al.
DRUG DISCOVERY TODAY (2017)
Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism
Xiao Feng et al.
CANCER LETTERS (2017)
hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers
Yang Xuan et al.
MOLECULAR ONCOLOGY (2016)
Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells
Jian-Jun Lu et al.
ONCOTARGET (2016)
A miR-335/COX-2/PTEN axis regulates the secretory phenotype of senescent cancer-associated fibroblasts
Tasnuva D. Kabir et al.
AGING-US (2016)
Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition
Sorski Liat et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Targeting Inflammation in Cancer Prevention and Therapy
Jelena Todoric et al.
CANCER PREVENTION RESEARCH (2016)
WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals
Xiangshu Xian et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Stromal COX-2 signaling are correlated with colorectal cancer: A review
Chen-Wei Su et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
The breast cancer stem cell potency of copper(II) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles
Arvin Eskandari et al.
DALTON TRANSACTIONS (2016)
The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers
Ebrahim Salehifar et al.
DRUG DISCOVERY TODAY (2016)
COX-2 inhibitors: a novel strategy in the management of breast cancer
Milosz Regulski et al.
DRUG DISCOVERY TODAY (2016)
Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway
Lu Gan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Resistance to 3-HTMC-Induced Apoptosis Through Activation of PI3K/Akt, MEK/ERK, and p38/COX-2/PGE2 Pathways in Human HT-29 and HCT116 Colorectal Cancer Cells
Josiane Semaan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma
Peter J. Cook et al.
NEURO-ONCOLOGY (2016)
Up-regulation of HB-EGF by the COX-2/PGE2 signaling associates with the cisplatin resistance and tumor recurrence of advanced HNSCC
Cheng-Chieh Yang et al.
ORAL ONCOLOGY (2016)
Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibition
Han-Yue Qiu et al.
PHARMACOLOGICAL RESEARCH (2016)
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
Sandrine Tury et al.
ONCOTARGET (2016)
JMJD2B is required for Helicobacter pylori-induced gastric carcinogenesis via regulating COX-2 expression
Fengjuan Han et al.
ONCOTARGET (2016)
Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway
Udo Walther et al.
ONCOTARGET (2016)
Disruption of tumour-host communication by downregulation of LFA-1 reduces COX-2 and e-NOS expression and inhibits brain metastasis growth
Manuel Sarmiento Soto et al.
ONCOTARGET (2016)
Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis
Sudeshna Goswami et al.
ONCOTARGET (2016)
Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells
Yang Lu et al.
ONCOTARGET (2016)
Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation
Xiaoming Rong et al.
ONCOTARGET (2016)
Inhibition of cancer cell epithelial mesenchymal transition by normal fibroblasts via production of 5-methoxytryptophan
Huei-Hsuan Cheng et al.
ONCOTARGET (2016)
Cyclooxygenase-2 induced β1-integrin expression in NSCLC and promoted cell invasion via the EP1/MAPK/E2F-1/FoxC2 signal pathway
Jinshun Pan et al.
SCIENTIFIC REPORTS (2016)
COX-2 modulates mammary tumor progression in response to collagen density
Karla Esbona et al.
BREAST CANCER RESEARCH (2016)
HGF-activated colonic fibroblasts mediates carcinogenesis of colonic epithelial cancer cells via PKC-cMET-ERK1/2-COX-2 signaling
F. Li et al.
CELLULAR SIGNALLING (2015)
Inhibition of PKC-Induced COX-2 and IL-8 Expression in Human Breast Cancer Cells by Glucosamine
Wan-Yu Chou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation
Mousumi Majumder et al.
MOLECULAR CANCER RESEARCH (2015)
Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
Ge Qin et al.
ONCOTARGET (2015)
Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis
Katja Hattar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib
Robert Ramer et al.
JOURNAL OF LIPID RESEARCH (2013)
Cell signalling by reactive lipid species: new concepts and molecular mechanisms
Ashlee Higdon et al.
BIOCHEMICAL JOURNAL (2012)
COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
Yuki Nakanishi et al.
CARCINOGENESIS (2011)
LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor
Yijun Gao et al.
PROTEIN & CELL (2011)
Acquired Activation of the Akt/Cyclooxygenase-2/Mcl-1 Pathway Renders Lung Cancer Cells Resistant to Apoptosis
Wenjie Chen et al.
MOLECULAR PHARMACOLOGY (2010)
Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor γ synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells
Wei-Hao Sun et al.
CANCER LETTERS (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction
Jeng-Wei Tjiu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The role of 15-deoxy-Δ12,14-prostaglandin J2, an endogenous ligand of peroxisome proliferator-activated receptor γ, in tumor angiogenesis
Eun-Hee Kim et al.
BIOCHEMICAL PHARMACOLOGY (2008)
15-Deoxy-Δ12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells:: a potential role of ROS
Eun-Hee Kim et al.
CARCINOGENESIS (2008)
Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers
Y. Liu et al.
ONCOGENE (2008)
Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis
Joyce E. Rundhaug et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2008)
Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation
Ellen Fritsche et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Overexpression of Cox-2 in human osteosarcoma cells decreases proliferation and increases apoptosis
Zheng Xu et al.
CANCER RESEARCH (2006)
COX-2 induces IL-11 production in human breast cancer cells
B Singh et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Cox-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectors
S. Lang et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2006)
Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11 - Cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation
TM Wagner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Is COX-2 a 'collateral' target in cancer prevention?
K Kashfi et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer
S Sharma et al.
CANCER RESEARCH (2005)
Prostaglandin E2 enhances intestinal adenoma growth via activation of the ras-mitogen-activated protein kinase cascade
DZ Wang et al.
CANCER RESEARCH (2005)
Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention
AJ Dannenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Endothelial cell integrins and COX-2:: mediators and therapeutic targets of tumor angiogenesis
C Rüegg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2004)
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer
K Krysan et al.
CANCER RESEARCH (2004)
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells
B Hinz et al.
MOLECULAR PHARMACOLOGY (2004)
Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-κB and pp38 mitogen-activated protein kinase
JH Hung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer
NK Altorki et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-κB and IκB kinase-α in human colorectal cancer epithelial cells
MP Charalambous et al.
BRITISH JOURNAL OF CANCER (2003)
Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines
M Noda et al.
JOURNAL OF GASTROENTEROLOGY (2002)
Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells
SC Ko et al.
ONCOGENE (2002)
Share Paper
